The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Aug 31, 2026
Snapshot (as of Aug 31, 2026): Roche Holding AG (RHHBY) pays a $1.23 annual dividend ($0.31 quarterly), yielding 2.75% at $55.19/share. Next ex-dividend date 2026-03-13. 8 consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 2.75%
Annual Dividend: $1.23 per share
Payout Ratio: 68.5%
Ex-Dividend Date: 2026-03-13
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 34
Roche Holding AG dividend has been a fixture in healthcare income portfolios for decades, backed by a business spanning oncology drugs, diagnostics, and treatments across immunology and neuroscience. The current yield stands at 2.75%, with a trailing annual dividend rate of $1.23 per share paid quarterly. The next ex-dividend date is March 13, 2026. With a beta of 0.347, RHHBY stock moves far less than the broader market, which suits income investors who prioritize low volatility over high yield.
Roche Holding AG pays out 68.5% of earnings as dividends, a payout ratio classified as elevated (60–75%). That level is supported by a broad product base spanning pharmaceutical treatments and laboratory diagnostics, including tests for cancer, diabetes, and hepatitis, which generate demand across economic conditions. Roche Holding AG dividend safety faces its clearest pressure from that payout ratio itself: at 68.5%, there is limited room to absorb an earnings decline without straining the dividend.
Roche Holding AG dividend history shows a CAGR of -2.8% per year from 2008 to 2025. Per-share payments moved from $2.2519 at the start of the window to $1.3890 by 2025 (the 2026 figure of $1.5495 reflects a partial year and is excluded from the CAGR calculation, per Roche Holding AG dividend 2026 data). The largest annual increase in the window was 27.1% in 2011, though the history also contains at least one year-over-year decline exceeding 5%, and the overall trend across the full window is negative.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +3.8% | $1.24 (2022) | $1.39 (2025) |
| 5-Year | +4.1% | $1.14 (2020) | $1.39 (2025) |
| 10-Year | +3.3% | $1.00 (2015) | $1.39 (2025) |
RHHBY fits dividend investors who want low market sensitivity and a moderate income stream from a global healthcare business. The yield of 2.75% sits in the moderate (2–4%) range and runs above the 5-year average of 2.35%, which means the current entry point offers more income than the historical norm. Eight consecutive years of dividend increases show a recent pattern of growth, but the long-term CAGR of -2.8% across the full history window is a real trade-off. What an investor gets here is a low-beta healthcare payer with a yield above its own historical average. What they accept is an elevated payout ratio and a long-run dividend trend that has moved downward.
| Payment Date | Amount per Share |
|---|---|
| 2026-03-13 | $1.5495 |
| 2025-03-28 | $1.3890 |
| 2024-03-14 | $1.3494 |
| 2023-03-16 | $1.2794 |
| 2022-03-17 | $1.2407 |
| 2021-03-18 | $1.2206 |
| 2020-03-19 | $1.1366 |
| 2019-03-07 | $1.0746 |
| 2018-03-15 | $0.8918 |
| 2017-03-15 | $0.8458 |
| Year | Total Dividends |
|---|---|
| 2026 | $1.5495 |
| 2025 | $1.3890 |
| 2024 | $1.3494 |
| 2023 | $1.2794 |
| 2022 | $1.2407 |
Project income from RHHBY with the RHHBY dividend calculator or track your full portfolio with the dividend tracker.